Page 114 - MI-2-3

Microbes & Immunity SARS-CoV-2 complementary classification

Dis. 2007;195(8):1177-1180. 129. Hirabara SM, Serdan TDA, Gorjao R, et al. SARS-COV-2
Variants: Differences and potential of immune evasion.
doi: 10.1086/512682
Front Cell Infect Microbiol. 2021;11:781429.
119. Palm AA, Esbjörnsson J, Månsson F, et al. Faster progression
to AIDS and AIDS-related death among seroincident doi: 10.3389/fcimb.2021.781429
individuals infected with recombinant HIV-1 A3/ 130. Jabeen M, Shoukat S, Shireen H, Bao Y, Khan A, Abbasi
CRF02_AG compared with sub-subtype A3. J Infect Dis. AA. Unraveling the genetic variations underlying virulence
2014;209(5):721-728. disparities among SARS-CoV-2 strains across global
regions: Insights from Pakistan. Virol J. 2024;21(1):55.
doi: 10.1093/infdis/jit416
doi: 10.1186/s12985-024-02328-8
120. Dorp CHV, Goldberg EE, Hengartner N, Ke R, Romero-
Severson EO. Estimating the strength of selection for new 131. Telenti A, Hodcroft EB, Robertson DL. The evolution and
SARS-CoV-2 variants. Nat Commun. 2021;12(1):7239. biology of SARS-CoV-2 variants. Cold Spring Harb Perspect
doi: 10.1038/s41467-021-27369-3 Med. 2022;12(5):a041390.
121. Tongo M, Harkins GW, Dorfman JR, et al. Unravelling the doi: 10.1101/cshperspect.a041390
complicated evolutionary and dissemination history of 132. Kim H, Webster RG, Webby RJ. Influenza virus: Dealing
HIV-1M subtype A lineages. Virus Evol. 2018;4(1):vey003. with a drifting and shifting pathogen. Viral Immunol.
doi: 10.1093/ve/vey003 2018;31(2):174-183.
122. Bedford T, Riley S, Barr IG, et al. Global circulation patterns doi: 10.1089/vim.2017.0141
of seasonal influenza viruses vary with antigenic drift. 133. Burrell CJ, Howard CR, Murphy FA. Chapter 2 - Classification
Nature. 2015;523(7559):217-220. of viruses and phylogenetic relationships. In: Burrell CJ,
doi: 10.1038/nature14460 Howard CR, Murphy FA, editors. Fenner and White’s
Medical Virology. 5 ed. United States: Academic Press;
th
123. Kwon Y, Park J, An E, Jung S, Kweon K. Impact of omicron- 2017. p. 15-25.
variant SARS-CoV-2 infection on depression and anxiety:
A community-based study in Korea. Psychiatry Investig. 134. Moya A, Holmes EC, González-Candelas F. The population
2024;21(4):415-421. genetics and evolutionary epidemiology of RNA viruses.
Nat Rev Microbiol. 2004;2(4):279-288.
doi: 10.30773/pi.2023.0323
doi: 10.1038/nrmicro863
124. Feng X, Yang C, Yang H, et al. Anxiety, depression, and
somatic symptom disorders in health care workers at 135. Geretti AM. HIV-1 subtypes: Epidemiology and significance
high altitude during the rapid spread of the SARS-CoV-2 for HIV management. Curr Opin Infect Dis. 2006;19(1):1-7.
Omicron variant: A prospective cohort study. Front doi: 10.1097/01.qco.0000200293.45532.68
Psychiatry. 2022;13:1018391.
136. Nastri BM, Pagliano P, Zannella C, et al. HIV and drug-
doi: 10.3389/fpsyt.2022.1018391 resistant subtypes. Microorganisms. 2023;11(1):221.
125. Janik E, Niemcewicz M, Podogrocki M, Majsterek I, Bijak M. doi: 10.3390/microorganisms11010221
The emerging concern and interest SARS-CoV-2 variants. 137. Santoro MM, Perno CF. HIV-1 genetic variability and
Pathogens. 2021;10(6):633.
clinical implications. ISRN Microbiol. 2013;2013:481314.
doi: 10.3390/pathogens10060633
doi: 10.1155/2013/481314
126. Hattab D, Amer MFA, Al-Alami ZM, Bakhtiar A. SARS- 138. Rambaut A, Posada D, Crandall KA, Holmes EC. The
CoV-2 journey: From alpha variant to omicron and its sub-
variants. Infection. 2024;52(3):767-786. causes and consequences of HIV evolution. Nat Rev Genet.
2004;5(1):52-61.
doi: 10.1007/s15010-024-02223-y
doi: 10.1038/nrg1246
127. Andre M, Lau LS, Pokharel MD, et al. From alpha to
omicron: How different variants of concern of the SARS- 139. Echeverría N, Moratorio G, Cristina J, Moreno P. Hepatitis C
Coronavirus-2 impacted the world. Biology (Basel). virus genetic variability and evolution. World J Hepatol.
2023;12(9):1267. 2015;7(6):831-845.
doi: 10.4254/wjh.v7.i6.831
doi: 10.3390/biology12091267
140. Martinez MA, Franco S. Therapy implications of hepatitis C
128. Thakur S, Sasi S, Pillai SG, et al. SARS-CoV-2 mutations
and their impact on diagnostics, therapeutics and vaccines. virus genetic diversity. Viruses. 2020;13(1):41.
Front Med (Lausanne). 2022;9:815389. doi: 10.3390/v13010041
doi: 10.3389/fmed.2022.815389 141. Sallam M, Khalil R. Contemporary insights into hepatitis C

Volume 2 Issue 3 (2025) 106 doi: 10.36922/MI025190042